Pharmaceutical News

RSS

Hospira announces availability of INFLECTRA (infliximab) in Canada

Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.

30 Mar 2015

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.

30 Mar 2015

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.

30 Mar 2015

Pain relief from IA injection may not predict better outcomes following arthroscopic hip surgery

How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery.

30 Mar 2015

Combination treatment improves outcomes in women with ovarian cancer

Medical researchers are always looking for ways to prevent or cure cancer. Given the complexity of this disease, reaching these milestones has been difficult.

30 Mar 2015

APrON study: Pregnant and lactating women not meeting recommended intake of omega-3

Alberta Pregnancy Outcomes and Nutrition (APrON) is a birth cohort involving over two thousand women and their infants from Calgary and Edmonton that was funded by Alberta Innovates Health Solutions and includes researchers at the University of Alberta and the University of Calgary.

30 Mar 2015

New report examines global issues affecting vaccine confidence since the new millennium

A decade on from the Northern Nigeria polio vaccination boycott and its global costs to the polio eradication initiative, a new report examines global issues affecting vaccine confidence and hesitation since the new millennium.

30 Mar 2015

CFDA accepts WuXi MedImmune's novel anti-IL6 monoclonal antibody IND application for review

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that an Investigational New Drug (IND) application for WuXi MedImmune's novel anti-IL6 monoclonal antibody for rheumatoid arthritis has been accepted for review by the China Food and Drug Administration.

29 Mar 2015

Anti-diabetic medication activates brain sensors, promotes weight gain

Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this drug to gain more body fat, according to researchers at Georgia State University, Oregon Health and Science University, Georgia Regents University and Charlie Norwood Veterans Administration Medical Center.

27 Mar 2015

Data demonstrates benefits associated with use of EXPAREL in hip, knee replacement patients

Pacira Pharmaceuticals, Inc. today announced data demonstrating the benefits associated with the use of EXPAREL (bupivacaine liposome injectable suspension) in a study of over 2,200 hip and knee replacement patients.

27 Mar 2015

New report explores global issues affecting confidence, hesitation about polio vaccines

A decade on from the Northern Nigeria polio vaccination boycott and its global costs to the polio eradication initiative, a new report examines global issues affecting confidence and hesitation about vaccines since the new millennium.

27 Mar 2015

Regeneron announces FDA approval of EYLEA (aflibercept) Injection for diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in patients with DME.

27 Mar 2015

WHO report: Access to new medicines requires transparency, collaboration

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult to afford them, according to a comprehensive study released today by the WHO Regional Office for Europe.

27 Mar 2015

Helsinn, Mundipharma sign distribution and license agreement for anamorelin

Helsinn, a Swiss Group focused on building quality cancer care, and Mundipharma, today announce that they have entered into a distribution and license agreement for the exclusive rights to anamorelin in China, Hong Kong and Macao.

26 Mar 2015

Novo Nordisk announces U.S. launch of Novoeight for people living with hemophilia A

Novo Nordisk today announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A.

From Novo Nordisk 26 Mar 2015

Inergetics announces launch of branded CBD-based nutritional supplement

Inergetics,Inc., a world-class developer of NSF Certified nutritional and consumer health products, announced today the launch of Nulief, a branded nutritional supplement offering the holistic benefits associated with Cannabidiol (CBD).

26 Mar 2015

Cellworld 2015 conference to be held in Downtown San Francisco on Sept. 21-22, 2015

Finesse Solutions announced Cellworld 2015, a new event that is specifically designed for innovators, visionaries and senior executives in bio-processing.

26 Mar 2015

Nanolek, Green Cross sign strategic deal to commercialize biologics in the Russian market

Green Cross, a South Korean biopharmaceutical company, and Nanolek, a Russian pharmaceutical company, today announced that they have entered into a strategic partnership agreement for the commercialisation of Green Cross' biologics in the Russian market.

26 Mar 2015

UVA researchers develop compound that could lead to improved leukemia treatments

Researchers at the University of Virginia School of Medicine have developed a compound that delays leukemia in mice and effectively kills leukemia cells in human tissue samples, raising hopes that the drug could lead to improved treatments in people. The researchers call it an exciting "new paradigm" for treating leukemia.

26 Mar 2015

AdverseEvents launches RxCost to determine economic impact of prescribing particular drugs

AdverseEvents Inc., a leading healthcare informatics company, today launched RxCost, the first methodology to identify the total costs of adverse drug reactions (ADRs) associated with FDA-approved drugs.

26 Mar 2015

Pharmaceutical News

Hospira announces availability of INFLECTRA (infliximab) in Canada

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Pain relief from IA injection may not predict better outcomes following arthroscopic hip surgery

Combination treatment improves outcomes in women with ovarian cancer

APrON study: Pregnant and lactating women not meeting recommended intake of omega-3

New report examines global issues affecting vaccine confidence since the new millennium

CFDA accepts WuXi MedImmune's novel anti-IL6 monoclonal antibody IND application for review

Anti-diabetic medication activates brain sensors, promotes weight gain

Data demonstrates benefits associated with use of EXPAREL in hip, knee replacement patients

New report explores global issues affecting confidence, hesitation about polio vaccines

Regeneron announces FDA approval of EYLEA (aflibercept) Injection for diabetic retinopathy

WHO report: Access to new medicines requires transparency, collaboration

Helsinn, Mundipharma sign distribution and license agreement for anamorelin

Novo Nordisk announces U.S. launch of Novoeight for people living with hemophilia A

Inergetics announces launch of branded CBD-based nutritional supplement

Cellworld 2015 conference to be held in Downtown San Francisco on Sept. 21-22, 2015

Nanolek, Green Cross sign strategic deal to commercialize biologics in the Russian market

UVA researchers develop compound that could lead to improved leukemia treatments

AdverseEvents launches RxCost to determine economic impact of prescribing particular drugs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News